Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mucosal delivery of vaccines.

Methods (San Diego, Calif.) - 1 Sept 1999

Del Giudice G, Pizza M, Rappuoli R

Abstract excerpt

Oral delivery represents one of the most pursued approaches for large-scale human vaccination. Due to the different characteristics of mucosal immune response, as compared with systemic response, oral immunization requires particular methods of antigen preparation and selective strategies of adjuvanticity. In this paper, we describe the preparation and use of genetically detoxified bacterial toxins as mucosal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Administration, Intranasal
Share to Cholera Toxin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterotoxins

Share to Gastric Mucosa

Share to Immunity, Mucosal

Share to Immunization

Share to Vaccines

Source

Identifiers

PMID: 10525451
DOI: 10.1006/meth.1999.0840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mucosal delivery of vaccines.PMID 10525451Read ↗

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.Semantic proximity Read ↗

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.Semantic proximity Read ↗

Genetically derived toxoids for use as vaccines and adjuvants.Semantic proximity Read ↗

Determining the activity of mucosal adjuvants.Semantic proximity Read ↗

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.Semantic proximity Read ↗

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccinesSemantic proximity Read ↗

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an updateSemantic proximity Read ↗

Challenges and opportunities in the development of mucosal mRNA vaccinesSemantic proximity Read ↗

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.Semantic proximity Read ↗

Bacillus subtilis comes of age as a vaccine production host and delivery vehicleSemantic proximity Read ↗

Gut-associated lactobacilli for oral immunisationSemantic proximity Read ↗

Live bacterial vaccines--a review and identification of potential hazards.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.